Related Experiment Video
Updated: Feb 15, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Systematic analysis reveals tumor-enhancing and -suppressing microRNAs in Drosophila epithelial tumors
Zhiqiang Shu1, Yi-Chun Huang1, William H Palmer1,2
1Department of Biological Science, Florida State University, Tallahassee, Florida, USA.
Abstract:
Despite their emergence as an important class of noncoding RNAs involved in cancer cell transformation, invasion, and migration, the precise role of microRNAs (miRNAs) in tumorigenesis remains elusive. To gain insights into how miRNAs contribute to primary tumor formation, we conducted an RNA sequencing (RNA-Seq) analysis of Drosophila wing disc epithelial tumors induced by knockdown of a neoplastic tumor-suppressor gene (nTSG) lethal giant larvae (lgl), combined with overexpression of an active form of oncogene Ras (Ras ), and identified 51 mature miRNAs that changed significantly in tumorous discs. Followed by in vivo tumor enhancer and suppressor screens in sensitized genetic backgrounds, we identified 10 tumor-enhancing (TE) miRNAs and 11 tumor-suppressing (TS) miRNAs that contributed to the nTSG defect-induced tumorigenesis. Among these, four TE and three TS miRNAs have human homologs. From this study, we also identified 29 miRNAs that individually had no obvious role in enhancing or alleviating tumorigenesis despite their changed expression levels in nTSG tumors. This systematic analysis, which includes both RNA-Seq and in vivo functional studies, helps to categorize miRNAs into different groups based on their expression profile and functional relevance in epithelial tumorigenesis, whereas the evolutionarily conserved TE and TS miRNAs provide potential therapeutic targets for epithelial tumor treatment.
Insights
MicroRNAs (miRNAs) play a role in cancer, but their exact function in tumor formation is unclear. This study identified specific tumor-enhancing and tumor-suppressing miRNAs in Drosophila, offering potential therapeutic targets for epithelial tumors.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are noncoding RNAs implicated in cancer progression, yet their specific roles in tumorigenesis require further elucidation.
- Understanding miRNA involvement in primary tumor formation is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the functional roles of microRNAs in epithelial tumorigenesis using a Drosophila model.
- To identify specific microRNAs that enhance or suppress tumor formation induced by neoplastic tumor-suppressor gene knockdown and oncogene activation.
Main Methods:
- RNA sequencing (RNA-Seq) was performed on Drosophila wing disc epithelial tumors.
- In vivo screens were conducted in sensitized genetic backgrounds to identify tumor-enhancing and tumor-suppressing miRNAs.
- Comparative analysis was performed to identify evolutionarily conserved miRNAs with human homologs.
Main Results:
- 51 mature miRNAs showed significant expression changes in tumorous discs.
- 10 tumor-enhancing (TE) and 11 tumor-suppressing (TS) miRNAs were identified.
- Four TE and three TS miRNAs possess human homologs, suggesting conserved functions.
Conclusions:
- This study categorizes miRNAs based on their expression and functional relevance in epithelial tumorigenesis.
- Evolutionarily conserved tumor-enhancing and tumor-suppressing miRNAs represent potential therapeutic targets for epithelial tumors.
Related Concept Videos
MicroRNAs
MicroRNAs
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

